These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37747361)
21. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery. He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888 [TBL] [Abstract][Full Text] [Related]
22. Size exclusion chromatography of plasmid DNA isoforms. Latulippe DR; Zydney AL J Chromatogr A; 2009 Aug; 1216(35):6295-302. PubMed ID: 19635618 [TBL] [Abstract][Full Text] [Related]
23. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles. Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542 [TBL] [Abstract][Full Text] [Related]
24. Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability. Gilbert J; Sebastiani F; Arteta MY; Terry A; Fornell A; Russell R; Mahmoudi N; Nylander T J Colloid Interface Sci; 2024 Apr; 660():66-76. PubMed ID: 38241872 [TBL] [Abstract][Full Text] [Related]
26. Characterization of mRNA Lipid Nanoparticles by Electron Density Mapping Reconstruction: X-ray Scattering with Density from Solution Scattering (DENSS) Algorithm. Dao HM; AboulFotouh K; Hussain AF; Marras AE; Johnston KP; Cui Z; Williams RO Pharm Res; 2024 Mar; 41(3):501-512. PubMed ID: 38326530 [TBL] [Abstract][Full Text] [Related]
27. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies. Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543 [TBL] [Abstract][Full Text] [Related]
28. Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccines. Malburet C; Leclercq L; Cotte JF; Thiebaud J; Bazin E; Garinot M; Cottet H Gene Ther; 2023 May; 30(5):421-428. PubMed ID: 36316446 [TBL] [Abstract][Full Text] [Related]
29. Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. Loughney JW; Minsker K; Ha S; Rustandi RR Electrophoresis; 2019 Sep; 40(18-19):2602-2609. PubMed ID: 31218707 [TBL] [Abstract][Full Text] [Related]
30. Payload distribution and capacity of mRNA lipid nanoparticles. Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112 [TBL] [Abstract][Full Text] [Related]
31. Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions. Unruh T; Götz K; Vogel C; Fröhlich E; Scheurer A; Porcar L; Steiniger F ACS Nano; 2024 Apr; 18(13):9746-9764. PubMed ID: 38514237 [TBL] [Abstract][Full Text] [Related]
32. Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. Maeki M; Uno S; Sugiura K; Sato Y; Fujioka Y; Ishida A; Ohba Y; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2024 Jan; 16(2):2110-2119. PubMed ID: 38141015 [TBL] [Abstract][Full Text] [Related]
34. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418 [TBL] [Abstract][Full Text] [Related]
35. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length. Mrksich K; Padilla MS; Joseph RA; Han EL; Kim D; Palanki R; Xu J; Mitchell MJ J Biomed Mater Res A; 2024 Sep; 112(9):1494-1505. PubMed ID: 38487970 [TBL] [Abstract][Full Text] [Related]
36. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311 [TBL] [Abstract][Full Text] [Related]
37. Size-Controllable and Monodispersed Lipid Nanoparticle Production with High mRNA Delivery Efficiency Using 3D-Printed Ring Micromixers. Hong J; Lee S; Park H; Ahn D; Lee JM; Choe H; Kim D; Kim JH; Chon CH ACS Appl Mater Interfaces; 2024 Sep; 16(35):46044-46052. PubMed ID: 39103250 [TBL] [Abstract][Full Text] [Related]
38. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA. Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764 [TBL] [Abstract][Full Text] [Related]
39. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging. M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519 [TBL] [Abstract][Full Text] [Related]
40. Elucidation of lipid nanoparticle surface structure in mRNA vaccines. Wang MM; Wappelhorst CN; Jensen EL; Chi YT; Rouse JC; Zou Q Sci Rep; 2023 Oct; 13(1):16744. PubMed ID: 37798336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]